Journal of Clinical Microbiology and Antimicrobials
Open Access

Understanding Antibodies: Their Structure and Importance in the Immune System

Gerard Wright^{* *}Correspondence: Gerard Wright, Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Canada, Email:

Author info »

Description

Immunoglobulins, also known as antibodies, are essential components of the immune system. They are proteins produced by plasma cells in response to the presence of foreign substances, such as bacteria, viruses, and toxins, in the body. Immunoglobulins play a critical role in protecting the body from infections and diseases by identifying and neutralizing harmful substances.

Functions of Immunoglobulins play several critical functions in the immune system. They recognize and bind to foreign substances, such as bacteria and viruses, through their antigenbinding sites, which are highly specific for each antigen [1]. This binding can neutralize the antigen or target it for destruction by other components of the immune system, such as phagocytes or complement proteins. Immunoglobulins also play a role in the clearance of dead cells and cellular debris through a process called opsonization. Opsonized particles are more easily recognized and engulfed by phagocytes, leading to their clearance from the body. Another essential function of immunoglobulins is the activation of the complement system. The complement system is a group of proteins that work together to destroy pathogens. When an immunoglobulin binds to an antigen, it can activate the complement system, leading to the formation of a membrane attack complex that can destroy bacterial cells.

Clinical applications of immunoglobulins

Immunoglobulins have several clinical applications in the diagnosis and treatment of diseases [2-4]. Immunoglobulin testing can be used to diagnose certain infections, autoimmune diseases, and immunodeficiencies. For example, the presence of antibodies in the blood is a sign of a recent infection, while the presence of antibodies indicates a past infection or immunity. Immunoglobulin therapy involves the administration of immunoglobulins to individuals with deficient immune systems or autoimmune diseases. The therapy can be administered intravenously or subcutaneously and is used to replace missing immunoglobulins or to modulate the immune system in autoimmune diseases [5].

Immunoglobulins can also be used as passive immunization in individuals at high risk of infections. For example, immunoglobulins containing antibodies against the hepatitis B virus can be administered to individuals who have been exposed to the virus to prevent infection.

In conclusion, immunoglobulins are essential components of the immune system that play a critical role in protecting the body from infections and diseases.

There are five main classes of immunoglobulins, each with a unique structure and function. Immunoglobulins recognize and bind to foreign substances, activate the complement system, and play a role in opsonization. Immunoglobulins have several clinical applications in the diagnosis and treatment of diseases and can be used for passive immunization and immunoglobulin therapy. Understanding the function and clinical applications of immunoglobulins is essential for the diagnosis and treatment of immune-related diseases [6]. They play a critical role in protecting the body from infections and diseases by identifying and neutralizing harmful substances.

Structure of antibodies

Antibodies are Y-shaped molecules composed of four polypeptide chains: two heavy chains and two light chains. The heavy chains are longer and have a more significant molecular weight than the light chains. The two heavy chains are joined by disulfide bonds, and each heavy chain is paired with a light chain. The chains are composed of amino acids and are arranged in a specific sequence that determines the antibody's unique structure and function. Opsonized particles are more easily recognized and engulfed by phagocytes, leading to their clearance from the body.

References

1. Cotter PD, Ross RP, Hill C. Bacteriocins—a viable alternative to antibiotics?. Nature Reviews Microbiology. 2013;11(2):95-105.

   [CrossRef] [Google Scholar] [Pubmed]

2. Kramer MG, Masner M, Ferreira FA, Hoffman RM. Bacterial therapy of cancer: promises, limitations, and insights for future directions. Front Microbiol. 2018;9:16.

   [CrossRef] [Google Scholar] [Pubmed]

3. Felgner S, Kocijancic D, Frahm M, Weiss S. Bacteria in cancer therapy: renaissance of an old concept. Int J Microbiol. 2016.

   [CrossRef] [Google Scholar] [Pubmed]

4. Nallar SC, Xu DQ, Kalvakolanu DV. Bacteria and genetically modified bacteria as cancer therapeutics: Current advances and challenges. Cytokine. 2017;89:160-172.

   [CrossRef] [Google Scholar] [Pubmed]

5.  Baindara P, Korpole S, Grover V. Bacteriocins: perspective for the development of novel anticancer drugs. Applied microbiology and biotechnology. 2018;102:10393-10408.

   [CrossRef] [Google Scholar] [Pubmed]

6. Brameyer S, Kresovic D, Bode HB, Heermann R. Dialkylresorcinols as bacterial signaling molecules. Proc Natl Acad Sci. 2015;112(2):572-7.

   [CrossRef] [Google Scholar] [Pubmed]